S100A8 and metabolic dysfunction-associated steatotic liver disease: Although we were unable to directly test this notion in patients due to the difficulty of obtaining paired liver and adipose tissues from the same patients, several lines of evidence support a link between adipocyte death and steatosis/MASLD in patients via the activation of S100A8+ macrophages.